K. A. Malle Pharmaceuticals Limited - Company Profile

It is a chemicals and materials public limited company based in Mumbai, Maharashtra, India, established in 1982.
1982 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About K. A. Malle Pharmaceuticals Limited

K. A. Malle Pharmaceuticals Limited, a active public limited company, was established on 11 May 1982 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U70101MH1982PLC027110. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹1.49 Cr.

Formerly known as K. A. Malle Leasing Company Limited. It upholds a compliant status. Employing 119 professional, Its leadership includes Shanu Pramod Podar (Director), Rahul Radheshyam Bhomavat (Director), Hemant Kumar Chaturvedi (Director). Past directors included Kamal Farokh Messman, Farokh Rustomji Messman, Shanu Pramod Podar. It holds ₹47.65 Cr open charges and ₹10.73 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2, Krishna Dham, L.S. Raheja Marg, Raheja Township, Malad East,, Mumbai, Maharashtra, 400097.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U70101MH1982PLC027110

  • Registration Number

    027110

  • Incorporation Date

    11 May 1982

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹1.49 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 1.49 Cr
  • Company Age 43 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 47.65 Cr
  • Satisfied Charges ₹ 10.73 Cr
  • Revenue Growth **** -14.13%
  • Profit Growth **** -406.16%
  • Ebitda **** -108.90%
  • Net Worth -180.34%
  • Total Assets -9.33%
Company report

K. A. Malle Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into K. A. Malle Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at K. A. Malle Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Shanu Pramod Podar Director 28 Feb 2014 Current
Rahul Radheshyam Bhomavat Director 08 Jun 2018 Current
Hemant Kumar Chaturvedi Director 08 Nov 2021 Current
Divyakumar Jain Director 08 Aug 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Feb 2008 Past
Pramod Abcsdd Director 08 Feb 2008 Past
Pramod Abcsdd Additional Director 30 Sep 2008 Past
Pramod Abcsdd Ceo(Kmp) - Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 06 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of K. A. Malle Pharmaceuticals.

K. A. Malle Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.13% decrease. The company also saw a substantial fall in profitability, with a 406.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 180.34%.

K. A. Malle Pharmaceuticals revenue growth over time
K. A. Malle Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -14.13%
*******
*******
*******
*******
Revenue from Operations
*******
 -16.73%
*******
*******
*******
*******
Total Assets
*******
 -9.33%
*******
*******
*******
*******
Profit or Loss
*******
 -406.16%
*******
*******
*******
*******
Net Worth
*******
 -180.34%
*******
*******
*******
*******
EBITDA
*******
 -108.90%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of K. A. Malle Pharmaceuticals?

In 2023, K. A. Malle Pharmaceuticals had a promoter holding of 99.96% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹476,500,000.00

Satisfied Charges

₹107,255,630.00

Charges Breakdown by Lending Institutions
  • The Cosmos Co-Operative Bank Ltd : 46.65 Cr
  • Standard Chartered Bank : 1.00 Cr
Latest Charge Details
Date Lender Amount Status
30 Jun 2008 The Cosmos Co-Operative Bank Ltd ₹46.65 Cr Open
06 Dec 1985 Standard Chartered Bank ₹1.00 Cr Open
09 Apr 2013 The Cosmos Co-Operative Bank Ltd. ₹5.00 M Satisfied
21 Apr 2012 The Cosmos Co-Op Bank Ltd ₹0.70 M Satisfied
23 Jul 2011 The Cosmos Co-Op Bank Ltd ₹7.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at K. A. Malle Pharmaceuticals?

K. A. Malle Pharmaceuticals has a workforce of 119 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of K. A. Malle Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K. A. Malle Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on K. A. Malle Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on K. A. Malle Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    K. A. Malle Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Hemant Kumar Chaturvedi was appointed as a Director was appointed as a Director on 08 Nov 2021 & has been associated with this company since 4 years 4 months . was documented.

  • Charges

    Progress on A charge registered on 21 Apr 2012 via Charge ID 10353329 with The Cosmos Co-Op Bank Ltd was fully satisfied on 05 Jul 2019. was documented.

  • Director Appointment

    The activity Divyakumar Jain was appointed as a Director was appointed as a Director on 08 Aug 2018 & has been associated with this company since 7 years 7 months . was completed.

  • Director Appointment

    The activity Rahul Radheshyam Bhomavat was appointed as a Director was appointed as a Director on 08 Jun 2018 & has been associated with this company since 7 years 9 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of K. A. Malle Pharmaceuticals Limited?

The CIN of K. A. Malle Pharmaceuticals Limited is U70101MH1982PLC027110.

Where is K. A. Malle Pharmaceuticals Limited headquartered?

K. A. Malle Pharmaceuticals Limited is headquartered at 2, Krishna Dham, L.S. Raheja Marg, Raheja Township, Malad East,, Mumbai, Maharashtra, 400097.

When was K. A. Malle Pharmaceuticals Limited incorporated?

K. A. Malle Pharmaceuticals Limited was incorporated on 11 May 1982.

Who are the current directors of K. A. Malle Pharmaceuticals Limited?

The current directors of K. A. Malle Pharmaceuticals Limited are

What is the primary industry of K. A. Malle Pharmaceuticals Limited?

The primary industry of K. A. Malle Pharmaceuticals Limited is Manufacturing.

Is K. A. Malle Pharmaceuticals Limited a listed company?

K. A. Malle Pharmaceuticals Limited is unlisted.

What is the capital structure of K. A. Malle Pharmaceuticals Limited?

The authorized capital of K. A. Malle Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹1.49 Cr.

What is the compliance status of K. A. Malle Pharmaceuticals Limited?

The compliance status of K. A. Malle Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available